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Guo ZL, Longhurst JC, Tjen-A-Looi SC, Fu LW. elPBN neu-
rons regulate rVLM activity through elPBN-rVLM projections during
activation of cardiac sympathetic afferent nerves. Am J Physiol Regul
Integr Comp Physiol 311: R410–R425, 2016. First published May 25,
2016; doi:10.1152/ajpregu.00127.2016.—The external lateral para-
brachial nucleus (elPBN) within the pons and rostral ventrolateral
medulla (rVLM) contributes to central processing of excitatory car-
diovascular reflexes during stimulation of cardiac sympathetic affer-
ent nerves (CSAN). However, the importance of elPBN cardiovascu-
lar neurons in regulation of rVLM activity during CSAN activation
remains unclear. We hypothesized that CSAN stimulation excites the
elPBN cardiovascular neurons and, in turn, increases rVLM activity
through elPBN-rVLM projections. Compared with controls, in rats
subjected to microinjection of retrograde tracer into the rVLM, the
numbers of elPBN neurons double-labeled with c-Fos (an immediate
early gene) and the tracer were increased after CSAN stimulation
(P  0.05). The majority of these elPBN neurons contain vesicular
glutamate transporter 3. In cats, epicardial bradykinin and electrical
stimulation of CSAN increased the activity of elPBN cardiovascular
neurons, which was attenuated (n  6, P  0.05) after blockade of
glutamate receptors with iontophoresis of kynurenic acid (Kyn, 25
mM). In separate cats, microinjection of Kyn (1.25 nmol/50 nl) into
the elPBN reduced rVLM activity evoked by both bradykinin and
electrical stimulation (n  5, P  0.05). Excitation of the elPBN with
microinjection of DL-homocysteic acid (2 nmol/50 nl) significantly
increased basal and CSAN-evoked rVLM activity. However, the
enhanced rVLM activity induced by DL-homocysteic acid injected into
the elPBN was reversed following iontophoresis of Kyn into the
rVLM (n 7, P 0.05). These data suggest that cardiac sympathetic
afferent stimulation activates cardiovascular neurons in the elPBN and
rVLM sequentially through a monosynaptic (glutamatergic) excit-
atory elPBN-rVLM pathway.
glutamate; neuronal activity; brain stem; heart; cardiovascular re-
sponses
ACTIVATION OF CARDIAC SYMPATHETIC afferent nerves, especially
during myocardial ischemia, causes cardiac pain and excitatory
reflex cardiovascular responses characterized by increases in
sympathetic outflow, elevations in blood pressure (BP) and
heart rate (HR), and tachyarrhythmia (11, 12, 24, 34). These
reflex responses increase the morbidity and mortality of pa-
tients with heart diseases, because they exacerbate the extent of
ischemia and infarction, which leads to severe heart failure and
lethal ventricular arrhythmias (11, 24, 34). We have demon-
strated that a number of metabolites produced during myocar-
dial ischemia, including bradykinin (BK) and adenosine 5=-
triphosphate (ATP), among others, activate cardiac sympa-
thetic afferent nerves (CSAN) and evoke sympathoexcitatory
reflex responses (11, 12, 24). However, how the central ner-
vous system processes inputs from CSAN and, ultimately,
regulates reflex cardiovascular responses is largely unknown.
Brain stem regions, such as the rostral ventrolateral medulla
(rVLM) and nucleus of the solitary tract (NTS), are crucial in
the regulation of cardiovascular function (1, 3, 7, 18, 22, 30).
We and others have identified a population of neurons that fire
in synchrony with the cardiac cycle and are sensitive to
baroreceptor activation in both nuclei (1–3, 18, 22). These cells
are classified as cardiovascular neurons (1–3, 18, 22). Cardio-
vascular neurons in the rVLM and NTS are involved in central
processing of reflex cardiovascular responses (3, 7, 8, 18).
Other studies have suggested that the lateral division of the
parabrachial nucleus (LPBN), including the external lateral
subdivision (elPBN), contains a heterogeneous population of
neurons involved in regulation of both respiratory and cardio-
vascular function (13, 23, 29). Some LPBN neurons have been
reported to mediate respiratory changes accompanying changes
in BP (23, 35). We have observed that cardiac sympathetic
afferent stimulation activates neurons in the elPBN (16, 17)
and evokes pressor reflexes that are reduced after inhibition of
the elPBN (11), suggesting that the cardiovascular neurons
responsive to cardiac afferent input likely also exist in the
elPBN. Thus the present study was designed to determine if
cardiovascular neurons are present in the elPBN and to exam-
ine their contribution to central processing of cardiac sympa-
thetic afferent input.
There are connections between PBN subnuclei and other
brain stem autonomic centers, including a connection between
the elPBN and the VLM (7, 13). The rVLM, specifically, is an
important brain region that critically controls sympathetic
outflow and cardiovascular function. Anatomical evidence
shows direct connections between the elPBN and the rVLM,
although their functional neurotransmitter system has not been
identified (35). Physiological studies in rats have shown that
chemical stimulation of the LPBN, including the elPBN, with
glutamate increases activity of the rVLM neurons (1, 28),
implying the existence of an excitatory connection between
these two nuclei. Although we have shown anatomically that
elPBN neurons are activated by cardiac sympathetic afferent
inputs (16, 17), whether these neurons project directly to the
rVLM and facilitate activation of rVLM cardiovascular neu-
rons through glutamate is not known.
Therefore, we hypothesized that cardiac sympathetic affer-
ent stimulation excites elPBN cardiovascular neurons and, in
turn, rVLM cardiovascular neurons through direct glutamater-
gic elPBN-rVLM connections. Using anatomical and electro-
physiological approaches, in the present study we sought to
identify elPBN cardiovascular neurons that are activated by
cardiac sympathetic afferent stimulation and directly project to
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the rVLM. Thus the present study investigated the influence of
elPBN neurons on the activity of rVLM cardiovascular neurons
through excitatory elPBN-rVLM projections associated with
glutamate during cardiac sympathetic afferent stimulation.
METHODS
All procedures in animals were carried out in accordance with the
guidelines of the American Physiological Society and the National
Institutes of Health. The minimum possible number of animals was
used to obtain reproducible and statistically significant results. In
addition, every effort was made to minimize discomfort and suffering.
Surgical and experimental protocols were approved by the Animal
Care and Use Committee at the University of California at Irvine.
Previous studies have shown that rats and cats display similar cardio-
vascular and autonomic responses to cardiac afferent nerve stimula-
tion. The central neural anatomy and circuits associated with process-
ing cardiac inputs are virtually identical in the rat and the cat (6, 7, 21,
25, 42, 49). The advantage of cats is their size, which facilitates
placement of multiple or closely spaced recording and stimulating
electrodes. Rats were used in tract-tracing studies requiring survival
for 7–10 days.
Anatomical Experiments
Microinjection of retrograde tracer into the rVLM. Adult male
Sprague-Dawley rats (350–500 g body wt) were used for microinjec-
tion of a retrogradely transported microsphere tracer into the rVLM to
visualize direct projections from the elPBN to the rVLM, as described
in our previous studies (31, 36). Briefly, a mixture of ketamine and
xylazine (80 and 12 mg/ml, respectively; Sigma Chemical, St. Louis,
MO) was used to induce (0.3–0.4 ml im) and maintain (0.1–0.2 ml
im) anesthesia in the animals. Body temperature was monitored with
a rectal probe and maintained at 37°C. HR and O2 saturation were
monitored using a pulse oximeter (Nonin Medical, Plymouth, MN).
After induction of anesthesia, rats were positioned in a stereotaxic
apparatus (David Kopf Instruments). A 1-inch incision was made to
expose the skull. A burr hole (4 mm diameter) was made in the bone
unilaterally, so that a glass micropipette could be inserted using the
following coordinates: 12.0–12.5 mm caudal from bregma, 2.0–2.5
mm lateral from midline, and 8.5 mm below the dural surface (31, 37).
Microinjection of DL-homocysteic acid (DLH, 2 nmol/50 nl) was used
to tentatively identify the location of the rVLM, noted as an increase
in HR. We then injected a retrogradely transported tracer (50 nl),
rhodamine-labeled fluorescent microspheres in suspension (0.04 m;
Molecular Probes, Eugene, OR), into the rVLM through a glass
micropipette (20- to 30-m tip diameter). After being taken up avidly
by presynaptic terminals (26, 44), the fluorescent microspheres filled
the cell soma. These fluorescent microspheres are not toxic to the
neuron, are easily recognized, and remain very stable for years. Thus
they are considered reliable retrograde tracers for examination of
neuronal pathways (44, 46). After microinjection of the microsphere
retrograde tracer, the wound was sutured shut.
Terminal procedures were carried out 7–10 days after administra-
tion of the retrograde tracer. Rats were reanesthetized with ketamine-
xylazine as described above. An adequate depth of anesthesia, as
judged by stability of respiration, BP, and HR and lack of a with-
drawal response to toe pinch, was maintained. A femoral artery and
vein were cannulated for measurement of arterial BP (model P 23 ID,
Statham, Oxnard, CA) and administration of drugs and fluids, respec-
tively. HR was derived from the arterial pressure pulse with a biotach
(Gould Instrument, Cleveland, OH). The animal was ventilated arti-
ficially through a cuffed endotracheal tube after intubation. Arterial
blood gases and pH were monitored with a blood gas analyzer (model
ABL-3, Radiometer, Westlake, OH) and kept within normal limits
(PO2 100–150 mmHg, PCO2 28–35 mmHg, pH 7.35–7.45) by adjust-
ment of the volume and/or the ventilation rate, enrichment of the
inspired O2 supply, and administration of 1 M NaHCO3. Body
temperature was maintained at 36–37.5°C by a water heating pad and
a heat lamp. Bilateral cervical vagotomy and barodenervation with
sectioning of carotid sinus nerves were performed to eliminate para-
sympathetic, as well as potentially baroreflex, inputs to the elPBN
during cardiac sympathetic afferent activation (16, 17). Successful
barodenervation was evaluated by the absence of reflex bradycardia
(decreases in HR by 21–25 vs. 0–3 beats/min, barointact vs. baroden-
ervated) when BP was increased [increases in mean arterial blood
pressure (MAP) by 23–27 vs. 18–24 mmHg, barointact vs. baroden-
ervated] following bolus injections of phenylephrine (1 g/100 g iv).
Experimental protocols. Rats subjected to microinjection of the
retrograde tracer into the rVLM were divided randomly into cardiac
sympathetic afferent stimulation and control groups. Similar to our
previous studies (16, 17), a small incision was made between the left
third and sixth ribs after removal of the fourth and fifth ribs to expose
the anterior surface of the heart. A pledget (0.6 cm2) of filter paper
soaked with a solution of ,-methylene-ATP (,-meATP) or 0.9%
normal saline was placed on the epicardial surface of the myocardium.
In the cardiac sympathetic afferent-stimulated group, 40-l doses of
,-meATP (0.2–0.6 mg/ml, leading to increases in BP) were applied
every 20 min for a total of six applications over a 100-min period (10).
In control animals, 0.9% normal saline, the vehicle for ,-meATP,
was applied repeatedly.
Immunohistochemical staining. TISSUE PREPARATION. As de-
scribed in our previous studies (31, 36), at 90 min after termination of
cardiac sympathetic afferent or control stimulation, deep anesthesia
was induced by another larger dose of ketamine-xylazine (0.5–0.7 ml
im). Transcardial perfusion was performed using 500 ml of 0.9%
saline solution followed by 500 ml of 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4). The pons and medulla oblongata were
removed and treated with 4% paraformaldehyde and 30% sucrose.
Coronal sections (30 m) were cut on a cryostat microtome (model
CM1850, Leica, Nussloch, Germany) to identify sites of microsphere
tracer injection and to perform immunohistochemical labeling, as
described below. Free-floating sections were used for labeling.
C-FOS IMMUNOHISTOCHEMICAL LABELING. Sections were stained
for c-Fos to identify elPBN cells activated by cardiac sympathetic
nerve stimulation (16, 17). After they were washed for 30 min (3
times for 10 min each) in phosphate-buffered saline containing 0.3%
Triton X-100 (PBST, pH 7.4), brain sections were placed for 1 h in
1% normal donkey serum (Jackson ImmunoResearch Laboratories,
West Grove, PA). The sections were incubated with a primary
polyclonal rabbit anti-Fos antibody (1:2,000 dilution; Oncogene Re-
search Products, Calbiochem, San Diego, CA) at 4°C for 48 h. After
they were rinsed three times in PBST, the tissues were incubated with
a fluorescein-conjugated donkey anti-rabbit antibody (1:200 dilution;
Jackson ImmunoResearch Laboratories) for 24 h at 4°C. Each section
was mounted on a slide and air-dried. Coverslips were mounted on the
slides using VECTASHIELD mounting medium for fluorescence
(catalog no. H-1000, Vector Laboratories, Burlingame, CA). In im-
munohistochemical control studies, all c-Fos staining was abolished
when 1 ml of the diluted primary antibody was preincubated with 5
g of the immunizing peptide corresponding to amino acids 4–17 of
human c-Fos (SGFNADYEASSSRC; catalog no. PP10, Oncogene
Research Products, Calbiochem). In addition, no labeling was de-
tected when the primary or secondary antibody was omitted.
DOUBLE-FLUORESCENT IMMUNOHISTOCHEMICAL LABELING FOR
C-FOS  VESICULAR GLUTAMATE TRANSPORTER 3. Vesicular gluta-
mate transporter (VGLUT) specifically transports glutamate into ves-
icles of neurons and, thus, offers a unique marker to distinctively
identify neurons that use glutamate as a neurotransmitter (9, 15, 17,
32). While VGLUT1 and VGLUT2 antisera mainly label nerve fibers,
VGLUT3 antiserum shows the staining pattern of both cell bodies and
nerve fibers (17, 32). We and others have shown that VGLUT3-
containing neurons are located in the PBN and are responsive to
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peripheral nerve stimulation (17, 48). To determine if c-Fos nuclei
were colocalized with the perikarya of rVLM-projecting glutamater-
gic neurons following stimulation of cardiac sympathetic afferents, we
selected VGLUT3 as the marker for glutamatergic neurons in the
present study. The staining procedures were similar to those used for
single-fluorescent immunohistochemical labeling described above.
Briefly, after treatment with PBST and 1% normal donkey serum,
brain tissues were incubated with two primary antibodies: a rabbit
polyclonal anti-c-Fos antibody (1:2,000 dilution) and a guinea pig
anti-VGLUT3 antibody (1:500 dilution; catalog no. AB5421, Chemi-
con, Temecula, CA) that was used to stain for cell bodies in the rat
(32) for 48 h at 4°C. Sections then were incubated with a coumarin-
conjugated donkey anti-rabbit antibody and a fluorescein-conjugated
donkey anti-guinea pig antibody (all 1:100 dilution; Jackson Immu-
noResearch Laboratories) at 4°C for 24 h. The sections were mounted
on slides, and mounting medium (Vector Laboratories) was used to
apply coverslips. In the immunohistochemical control studies, no stain
was detected when the primary or secondary antibody was omitted. In
addition, the specificity of the VGLUT3 antibody was verified further
by preabsorption with an excess amount (10 g/ml) of VGLUT3
peptide (Chemicon).
DATA ANALYSIS. Brain sections were scanned and examined with
a standard fluorescence microscope (model E400, Nikon, Melville,
NY) that was equipped with three epifluorescence filters (B-2A,
G-2A, or UV-2A) to detect green, red, and blue colors. Sections
containing the elPBN were identified according to their best-matched
standard stereotaxic plane, as shown in the atlas of Paxinos and
Watson for the rat (37). Two sections were selected for each of two
representative planes (bregma 9.00 and 9.24 mm; Fig. 2) of the
pons that contain elPBN in all animals.
Selected sections were further evaluated with a laser scanning
confocal microscope (LSM 510, Meta System, Zeiss, Thornwood,
NY) to confirm colocalization of two or three labels. This apparatus
was equipped with argon and HeNe lasers and allowed operation of
multiple channels. Lasers of 488- and 543-nm wavelengths were used
to excite fluorescein (green) and rhodamine (red), respectively. A
790-nm laser was applied for two-photon excitation of coumarin
(blue). Digital fluorescent images were captured and analyzed with
software (Zeiss LSM) provided with the confocal microscope. Each
confocal section analyzed was limited to 0.5-m thickness in the z
plane. Images containing two or three colors in the same plane were
merged to reveal the relationship between two or three labels (Fig. 1).
In each animal, the number of single-, double-, and/or triple-labeled
cells was counted. The proportion of the double-labeled neurons
relative to single-labeled neurons was calculated as a percentage. The
average of these values, derived from the two representative planes
(Fig. 2), was used to represent the average value of these data per
section for statistical analysis (16, 17).
Physiological Experiments
Animal preparations. GENERAL SURGICAL PREPARATION. Studies
were performed in cats (2.9–4.6 kg body wt) of either sex. The
animals were preanesthetized with ketamine (20–30 mg/kg im) and
anesthetized with -chloralose (40–50 mg/kg iv) through the femoral
vein. Additional -chloralose (5–10 mg/kg iv) was given as needed to
maintain an adequate depth of anesthesia, assessed by observing the
absence of a conjunctival reflex. The trachea was intubated with a
cuffed endotracheal tube, and respiration was maintained artificially
(model 661, Harvard ventilator, Ealing, South Natick, MA). Arterial
blood gases and body temperature were maintained within physiolog-
ical limits as described above in the rat subjected to terminal surgical
procedures. To vagotomize the animals, parasympathetic branches of
vagus nerves to the heart and lungs were cut bilaterally 	1 cm above
the aortic arch.
CARDIAC SYMPATHETIC NERVE STIMULATION. We have described
chemical and electrical cardiac sympathetic nerve stimulations in
detail in our previous studies (18, 41). Briefly, to chemically stimulate
CSAN, a small incision was made through the left fourth or fifth
intercostal space to expose the pericardium. A PE-60 catheter with six
perforations in its distal end was introduced into the pericardium for
intrapericardial application of BK and 0.9% normal saline. To elec-
trically stimulate CSAN, the left inferior cardiac branch of the
sympathetic nerve was isolated through a sternotomy approach. A
bipolar flexible platinum stimulating electrode was placed around the
intact nerve branch. The stimulating electrode was connected to an
isolation unit and stimulator (model S88, Grass Instruments) to deliver
bipolar stimuli. Slight increases in BP (5–10 mmHg) and HR (	10
beats/min) following electrical stimulation (2 Hz and 0.5-ms pulses at
1–4 mA) confirmed correct isolation of cardiac sympathetic nerves
(41). CSAN-induced activity in the elPBN and rVLM was obtained
with a lower intensity (	0.4 mA) of stimulation that did not cause
changes in BP and HR. The stimulating electrode was held in place
with epoxy dental glue (Pentron, Wallington, CT). After these proce-
dures, the ribs were approximated and the chest was closed.
RENAL SYMPATHETIC NERVE ACTIVITY. To correlate renal sympa-
thetic nerve activity (RSNA) with rVLM discharge activity, multiunit
RSNA was recorded as described previously (18, 31, 36). Briefly,
under a dissecting microscope, a branch of the renal nerve from
surrounding connective tissue was isolated and cut distally to elimi-
nate afferent discharge. The nerve was covered with warm mineral oil
and placed across one pole of a bipolar recording electrode that was
attached to a high-impedance probe. The other pole of the recording
electrode was grounded with a normal saline-presoaked cotton thread
to the animal. The signals were amplified and processed through an
audio amplifier with the low-frequency cutoff set at 30 Hz and the
high-frequency cutoff set at 3 kHz. The amplified signals were
processed and recorded with a computer through an analog-to-digital
converter for subsequent off-line analysis. Discharge activity of the
renal sympathetic nerve was analyzed with data acquisition-and-
analysis software (Spike 2, Cambridge Electronic Design). Electrical
noise level in neural recordings was determined after the nerves were
crushed at the end of the experiment.
ACCESSING BRAIN NUCLEI. Animals were placed in a stereotaxic
head frame (Kopf Instruments). A craniotomy was performed to
expose the dorsal surface of the brain stem for unilateral microinjec-
tion, stimulation, and recording of extracellular activity in the same
side of the elPBN and rVLM (11, 31, 36). To access the elPBN, we
performed a unilateral cerebellectomy to visualize the surface of the
pons. A single- or multi-barrel glass micropipette was positioned
9.5–11 mm rostral to obex, 5.0–5.4 mm lateral to midline at a 90°
angle to the dorsal surface of the pons at a depth of 0.8–1.8 mm to
reach the elPBN (4, 11, 16, 17, 35). To access the rVLM, the glass
micropipette was positioned 2.9–3.5 mm rostral to obex and 3.0–3.6
mm lateral to midline at a 90° angle to the dorsal surface of the
medulla at a depth of 5.0 mm (36, 42). The glass micropipette was
positioned by a micromanipulator (Kopf). The locations of the elPBN
and rVLM were identified preliminarily by the pressor and tachycar-
dia responses during chemical (e.g., DLH) stimulation and confirmed
histologically after the experiment.
MICROINJECTION AND IONTOPHORESIS IN BRAIN NUCLEI. Unilat-
eral microinjection (50 nl) of a chemical was performed using a glass
micropipette (15- to 20-m tip diameter) that was connected to a
microsyringe injector (model UMP3) and contained a 10-l Hamilton
syringe (WPI, Sarasota, FL) (11). To record and iontophorese a
chemical into the same neuron, we used a triple-barrel glass pipette
electrode (	3-m maximum total tip diameter) to record neuronal
activity and to iontophorese the chemical in the area of interest (18,
42). One barrel of the pipette electrode was filled with the chemical.
Another barrel contained a platinum recording electrode with 0.5 M
sodium acetate containing 2% Chicago sky blue (Sigma Chemical).
The third barrel was filled with 3 M sodium chloride to balance the
current in the iontophoresis system (Neurophore BH2 system, Med-
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ical Systems, Greenvale, NY). The retention current for balancing
was 25 to 10 nA. The chemical was injected over a 2-min period
with 10- to 120-nA currents, depending on the structure of the injected
chemical.
SINGLE-UNIT EXTRACELLULAR RECORDING AND IDENTIFICATION
OF A CARDIOVASCULAR NEURON. A glass micropipette containing a
platinum electrode was advanced ventrally in 1- to 2-m steps toward
the elPBN or rVLM to detect spontaneous neuronal activity or activity
evoked by electrical CSAN stimulation (2 Hz). The neuronal activity
was amplified with a preamplifier (model P511, Grass Instruments)
attached to a high-impedance probe (model H1P5, Grass Instruments)
and then filtered (0.3–10 kHz) and monitored with an oscilloscope
(Tektronix 2201). The neuronal signals then were transferred to a
computer for analysis (Spike 2). Care was taken to minimize the
influence of respiratory and BP change-related movements on the
recorded neuronal activity by application of a bilateral pneumothorax
and administration of gallamine triethiodide (4 mg/kg iv) every 2 h.
Spike discrimination was closely monitored throughout the experi-
ment. To characterize a cardiovascular neuron, its barosensitivity was
tested by recording changes in discharge rate in response to a decrease
and/or an increase in BP elicited by administration of nitroglycerin
(50 g/kg iv) and/or phenylephrine (2.5 g/kg iv), respectively. For
further characterization, spontaneous activity was recorded for 300 s. The
presence of rhythmicity related to the cardiac cycle (i.e., cardiac
rhythmicity) in the spontaneous neuronal activity was determined by
evaluation of pulse synchronization with frequency and time domain
analyses. After identification of the neuron, analysis of peristimulus
histograms was used to examine evoked responses to electrical CSAN
stimulation (30 stimuli at 2 Hz) and BK was used to examine
responses to epicardial stimulation. To determine sympathetic activity
of the cardiovascular neuron in the rVLM, the relationship between
rVLM neuronal activity and RSNA also was assessed with both time
and frequency domain analyses using spike-triggered averaging and
coherence analysis, as described below.
To determine direct functional projections of cardiovascular
elPBN neurons to the rVLM, we identified antidromically evoked
elPBN neuronal activity by stimulating the rVLM at a frequency of
2 Hz for 0.5 ms, as we and others have described previously (31,
Fig. 1. Histological staining in the external lateral parabrachial nucleus (elPBN) and the rostral ventrolateral medulla (rVLM). A1–A3: photomicrographs
demonstrating a microinjection site of the retrograde microsphere tracer in the rVLM [bregma 12.12 mm; from the rat brain atlas of Paxinos and Watson (37)].
A1: bright-field image of a medulla section. A2: fluorescence image showing the microinjection site of the retrograde microsphere tracer in the medulla section.
A3: merged image from A1 and A2. Arrows in A2 and A3 indicate the injection site located in the rVLM. B and C: confocal microscopic images showing double
(B1–B4) and triple (C1–C4) fluorescent labeling in the elPBN (bregma 9.00 mm) of a rat following stimulation of cardiac sympathetic afferent nerves with
epicardial application of ,-methylene-ATP (,-meATP, 8 g). B1: low-power photomicrograph. B2: higher magnification of the region within the box
(located in the elPBN) in B1. B2 is a merged image from B3 and B4. Arrows in B2, B3, and B4 indicate a neuron labeled with c-Fos  tracer, c-Fos (green),
and tracer (red), respectively. SCP, superior cerebellar peduncle. Arrows in C1, C2, C3, and C4 indicate a neuron containing c-Fos (blue), retrogradely transported
microspheres originating from the rVLM (red), vesicular glutamate transporter 3 (green), and colocalization of the 3 labels.
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33, 36, 42). Briefly, elPBN neurons that responded to antidromic
stimulation were examined for constant latency, stable threshold of
the evoked all-or-none response, and a faithful response to high
rates of stimulation (
200 Hz). Then these elPBN neurons were
evaluated for collision of rVLM-evoked antidromic action poten-
tials and orthodromic activity evoked by CSAN. The refractory
period was also measured to determine the critical time interval
(latency  refractory period) during which the ortho- and anti-
dromic spikes collide. The conduction velocity of elPBN neurons
was determined from the distance between the recording and
stimulating electrodes and the antidromic latency.
HISTOLOGY. At the end of each experiment, the medulla and
pons were removed and submerged in 10% paraformaldehyde
for 2 days. Frozen coronal 50-m sections were cut with a
microtome cryostat (Leica). Sites of microinjection and iontopho-
resis were marked by spots of Chicago sky blue and identified
according to the atlas of Berman (4, 11, 18, 36).
DRUGS. Kynurenic acid (Kyn, 25 mM) is a specific glutamate
ionotropic receptor antagonist (11, 45); DLH (40 mM) is a specific
glutamate ionotropic receptor agonist (38, 47). Each drug was
dissolved in artificial cerebrospinal fluid (aCSF, pH 7.4) or 0.9%
normal saline mixed with Chicago sky blue (2%) for subsequent
histological site verification (18). For epicardial stimulation, we
used ,-meATP (0.2– 0.6 mg/ml), a specific P2X1 and P2X3
receptor agonist, or BK (1–10 g/ml); both were dissolved in 0.9%
normal saline. As demonstrated in our previous studies, consistent
pressor responses were observed in the rat with repeated epicardial
application of ,-meATP (10) and in the cat with BK (11, 18, 19).
Thus, ,-meATP and BK were administered to the rat and cat,
respectively. All chemicals were purchased from Sigma-Aldrich,
prepared weekly, and stored in a freezer at 20°C.
Experimental Protocols
Excitation of elPBN cardiovascular neurons in response to CSAN
stimulation through activation of glutamate receptors. Only elPBN
cardiovascular neurons were selected for study in this protocol. To
identify direct elPBN-rVLM projections, in some cases, we exam-
ined the activity of elPBN cardiovascular neurons evoked by
antidromic stimulation in the rVLM. To examine the responses of
elPBN cardiovascular neurons to cardiac afferent stimulation, we
recorded their responses to epicardial application of BK (1–10
g/ml, 50 l) and electrical CSAN stimulation (30 stimuli at 2
Hz). The dose of BK was based on previous studies (11, 16, 18).
Finally, we measured the responses of the elPBN neuron to
chemical and electrical CSAN stimulations 5 min after iontopho-
resis of Kyn (25 mM) with currents of 80 –120 nA or 0.9% normal
saline (vehicle for Kyn) into the elPBN to determine the role of the
glutamate receptors in excitation of elPBN cardiovascular neurons
during CSAN stimulation. This dose of Kyn in the elPBN markedly
attenuates sympathoexcitatory reflex responses induced by cardiac
stimulation with BK (11).
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Fig. 2. Distribution of c-Fos immunoreactivity and/or cells labeled with retrograde microsphere tracer in the elPBN following epicardial stimulation with
,-meATP (8 g) and in a sham-operated control. Two coronal sections of the pons ipsilateral to the tracer injection in the rVLM [atlas of Paxinos and
Watson (37)] were selected from 1 animal in each experimental group. Each symbol represents a labeled cell(s). SCP, superior cerebellar peduncle; PBN,
parabrachial nucleus; LPBN, lateral PBN; LPBNc, central part of LPBN; LPBNcr, crescent part of LPBN; LPBNd, dorsal part of LPBN; LPBNe, external
part of LPBN; LPBNi, internal part of LPBN; LPBNv, ventral part of LPBN; MPBN, medial PBN; MPBNe, external part of MPBN; KF, Kölliker-Fuse
nucleus.
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Response of the rVLM cardiovascular neuron during CSAN stim-
ulation before and after blockade of glutamate ionotropic receptors in
the elPBN or rVLM. A single-barrel micropipette was positioned into
the elPBN for microinjection, and a single- or triple-barrel micropi-
pette was positioned in the ipsilateral rVLM for recording and ionto-
phoresis in a cat. An rVLM cardiovascular neuron was identified as
described in SINGLE-UNIT EXTRACELLULAR RECORDING AND IDENTIFICA-
TION OF A CARDIOVASCULAR NEURON. In addition, to characterize the
rVLM cell with sympathetic activity, the relationship between rVLM
neuronal activity and RSNA was evaluated by RSNA spike-triggered
averaging and coherence analyses. After identification, we conducted
the following protocols.
In protocol 1, we examined rVLM activity in response to CSAN
stimulation before and after microinjection of Kyn into elPBN. At 20
min following identification of an rVLM cardiovascular neuron re-
sponsive to CSAN input, we microinjected Kyn (1.25 nmol/50 nl) into
the ipsilateral elPBN. Then we evaluated the rVLM response to
epicardial stimulation with BK (1–10 g/ml in 50 l) and electrical
CSAN stimulation. Control animals were assessed in an identical
manner with elPBN microinjection of the vehicle, aCSF.
In protocol 2, we evaluated the responses of rVLM neurons during
DLH-induced elPBN excitation in the absence and presence of CSAN
stimulation before and after iontophoresis of Kyn into the rVLM.
After identification of an rVLM cardiovascular neuron responsive to
chemical and electrical CSAN stimuli, we measured basal and CSAN-
evoked rVLM activity before and after microinjection of DLH (2
nmol/50 nl) into the ipsilateral elPBN. The dose of DLH was shown
to significantly excite neurons (38, 47). After 20 min, Kyn or vehicle
(0.9% normal saline) was iontophoresed into the rVLM and the elPBN
was stimulated again with DLH. We then reassessed basal and
CSAN-evoked rVLM activity before and after microinjection of DLH.
Since aCSF was the vehicle for DLH, microinjection of aCSF into the
elPBN described in protocol 1 also served as the control for micro-
injection of DLH into the elPBN in protocol 2.
NEUROPHYSIOLOGICAL DATA ANALYSIS. RSNA and single-unit
extracellular recordings were evaluated and analyzed during and after
experiments. Action potentials were assessed visually and with the
Spike 2 program using wave-shape recognition algorithms to allow
detection of similar wave shapes and heights. A window discriminator
was set just above the noise level, so that only renal nerve discharge
was counted. Nerve discharge also was rectified and averaged over a
10-s period with the software (Spike 2) to assess integrated RSNA
(11, 18).
The activity of the elPBN or rVLM neurons in response to chem-
ical stimulation with BK or to baroreceptor loading/unloading is
presented as the average of the total number of spikes over time
[impulses (imp)/s]. Peristimulus time histogram analysis was used to
quantitatively assess elPBN and rVLM neuronal responses during
brief electrical CSAN stimulation (30 stimuli over 15 s), as described
previously (31, 42). As shown in Fig. 7, the analysis occurred over 0.5 s,
beginning 0.1 s before and lasting 0.1–0.4 s after electrical CSAN
stimulation. Evoked activity by CSAN stimulation during the 30
stimuli was calculated as the sum of spikes during 0.1 s of the peak
response poststimulation minus spikes over a similar time period
recorded immediately before stimulation. Thus it indicated the total
evoked discharge induced by 30 CSAN stimuli over and above
baseline.
COHERENCE ASSESSMENT. Frequency domain analysis was used
to assess coherence of elPBN or rVLM neuronal activity with
arterial BP or RSNA using a fast Fourier transform algorithm (18,
27, 31, 42). We recorded data using a sampling rate of 10,000 Hz
(see Fig. 3). The original data were reconstructed by averaging
every 10 points to a single point that provided a new sampling rate
of new data series of 1,000 Hz. In the resampled data series, BP
was generated from the mean of 10 coterminous original values.
The value of the neural activity was obtained from the mean,
maximum, and minimum data from the slope and amplitude of the
original spike to preserve action potentials. The spikes were sorted
and identified with a window discriminator to construct histograms.
The number of data sections (15–20, each lasting 12.8 s) was chosen to
determine the average histogram. Thus coherence was generated with
seven overlapping windows, each with a duration of 12.8 s, consisting
of 256 bins with 50-ms bin widths. The autospectral analysis was
adopted from Shin et al. (40) using contiguous segments of 256 beats
with 50% overlap between the segments. The frequency resolution
was 1/12 s or 0.08 Hz. The coherence function (normalized cross-
spectrum) provided a measure of the strength of the linear correlation
of two signals at each frequency (see Statistical Analysis).
SPIKE AND PULSE-TRIGGERED AVERAGING. Time domain analysis
was used to evaluate the relationship in time between the activity of
elPBN or rVLM neurons and arterial BP or RSNA (18, 27, 31, 42).
Neuronal activity tightly related in time to BP pulse or RSNA
provides a measure of the time relationship between the neuron and
cardiovascular/sympathetic activity (Figs. 3 and 6). This analysis
involved arterial pulse- and renal sympathetic nerve spike-triggered
averaging. A threshold was set at the systolic phase of the arterial
pulse or the action potentials of the renal sympathetic nerve, while
spike height discrimination and waveform recognition were used to
sort action potentials of the neuron during the 300-s evaluation period.
Averages of the arterial pulse or RSNA histogram and histograms of
neuronal activity were constructed as demonstrated in our previous
studies (18, 31, 36).
Statistical Analysis
Values are means  SE. Effects of repeated interventions were
compared using a one-way repeated-measures ANOVA with Tukey’s
post hoc test. If data were not normally distributed, as determined by
the Kolmogorov-Smirnov test, they were compared using Friedman’s
repeated-measures ANOVA on ranks with Dunnett’s post hoc test.
Comparisons between two groups were analyzed with Student’s t-test
or the Mann-Whitney U-test. Statistical calculations were performed
with Sigmastat software (Jandel Scientific Software, San Rafael, CA).
Differences were considered statistically significant when P  0.05.
In addition, coherence values 0.5 were chosen to reflect a statisti-
cally significant relationship between neuronal activity of the elPBN
or rVLM and arterial BP or RSNA (18, 31, 36, 42).
RESULTS
Activation of rVLM-Projecting elPBN Neurons in Response
to CSAN Stimulation
Eleven rats in which the unilateral microinjection site of the
retrograde tracer was found inside the rVLM (Fig. 1) were
included in the study. The locations of injected tracer in the
medulla closely matched the coordinates of the rVLM as
defined by the atlas of Paxinos and Watson for the rat (37). The
microinjection sites in the rat were located 12.0–12.48 mm
caudal to bregma, 2.0–2.6 mm lateral from midline, and
0.2–0.7 mm from the ventral surface of the medulla. They
were lateral to the paragigantocellularis nucleus, ventral to the
Bötzinger complex, and medial to the VII cranial nucleus at the
high rostral level (31, 37). Neurons labeled with the retrograde
microsphere tracer were observed in the Kölliker-Fuse nucleus,
medial PBN, and lateral PBN, including dorsal, ventral, cen-
tral, and external lateral nuclei (Fig. 2). They were evaluated
especially in the elPBN. We noted that approximately two-
thirds of the neurons labeled with microspheres in the elPBN
were located ipsilateral to the site of the unilateral injection
into the rVLM. Microsphere-labeled elPBN neurons ipsilateral
to the rVLM injection were counted. The number of neurons
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labeled with the retrograde microsphere tracer in the elPBN
was similar in the CSAN-stimulated and control rats (Fig. 2,
Table 1).
Fos-labeled neurons were noted in the Kölliker-Fuse nucleus
and lateral PBN, including its ventral, central, and external
lateral subdivisions, particularly in the elPBN (Figs. 1B and 2)
The number of Fos-labeled neurons in the elPBN was in-
creased significantly in the CSAN-stimulated group (n  6)
compared with the control group (n  5; Table 1), consistent
with our previous findings in the cat (16, 17). In the present
study we found more elPBN neurons labeled with the retro-
grade tracer and c-Fos in the CSAN-stimulated than control
rats (Fig. 2, Table 1). The proportion of elPBN double-labeled
neurons projecting to the rVLM was significantly greater in the
CSAN-stimulated than control group (Table 1). Figure 1,
B1–B4, displays confocal images of neurons double-labeled
with c-Fos and the retrogradely transported microspheres in the
elPBN of a rat subjected to CSAN stimulation. Furthermore,
neurons triple-labeled with c-Fos, the retrograde tracer, and
VGLUT3, as demonstrated in Fig. 1, C1–C4, were frequently
(6  1 cells per section) identified in the elPBN of four rats
following CSAN stimulation but rarely noted (1  1 cells per
section) in three controls. There was a significant difference in
the number of triple-labeled neurons between these two groups
(P  0.05). The number of VGLUT3-labeled neurons in the
elPBN was similar in the CSAN-stimulated and control rats.
Fig. 3. Identification of a cardiovascular neuron in the
elPBN. A: phenylephrine increased blood pressure (BP)
and reduced neuronal activity (NA). B: time domain
analysis using pulse-triggered averaging shows a rela-
tionship between BP and NA. C: frequency domain
analysis shows a significant coherence (0.65 with fre-
quency of 2.89 Hz) between BP and NA. B and C
demonstrate cardiac rhythmicity of the elPBN neuron.
D: NA and BP in response to stimulation of cardiac
sympathetic afferent nerves with epicardial application
of bradykinin (BK). Top: neuronal traces displaying
NA; bottom: original recordings of BP. Arrow indicates
BK application. AS, autospectra.
Table 1. c-Fos immunoreactivity and colocation with retrograde tracer in the elPBN following stimulation of CSAN
n Fos-Positive Cells, no. Tracer-Positive Cells, no. Tracer  Fos-Positive Cells, no.
Tracer  Fos-Positive Cells
%Tracer-positive cells %Fos-positive cells
Control 5 4  1 28  2 2  1 7  3 34  10
CSAN stimulation 6 19  3** 31  4 8  1** 29 7* 44  2
Values are means  SE. Number of c-Fos-positive cells, neurons labeled with retrograde microsphere tracer injected into the rostral ventrolateral medulla
(rVLM), and cells with both stains in the external lateral parabrachial nucleus (elPBN) are expressed per section ipsilateral to rVLM injection. Also shown is
percentage of double-labeled neurons relative to number of tracer-labeled neurons or Fos-positive cells. CSAN, cardiac sympathetic afferent nerves. *P  0.05,
**P  0.01 vs. control.
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Increase in Activity of elPBN Cardiovascular Neurons by
CSAN Stimulation Through Activation of Glutamate
Ionotropic Receptors
In 14 cats, we found 17 elPBN neurons responsive to
activation of baroreceptors. We observed that their activity was
increased from 2.02  0.35 to 3.14  0.36 imp/s (P  0.05)
when MAP was lowered from 103  9 to 48  2 mmHg
following intravenous nitroglycerin and decreased from 2.45
0.33 to 1.34  0.28 imp/s (P  0.05) when MAP was raised
from 99  6 to 172  5 mmHg with intravenous phenyleph-
rine (Fig. 3A). Their responses to baroreceptor activation began
at 	15–30 s and lasted for 90–150 s. These barosensitive cells
were also tested for cardiac rhythmicity (Fig. 3, B and C) based
on the time and frequency (coherence 0.7 0.2 at 3 0.4 Hz)
domain analyses. We identified 12 cells displaying both baro-
sensitivity and cardiac rhythmicity, i.e., cardiovascular neu-
rons. These 12 cardiovascular neurons were responsive to both
chemical (e.g., BK; Fig. 3D) and electrical CSAN stimulations.
Their responses to epicardial application of BK started at
	8–12 s and lasted for 40–90 s. Two of the 12 elPBN
cardiovascular cells responsive to CSAN stimulation were
classified further as rVLM-projecting neurons, since they were
activated by antidromic stimulation of the rVLM, were faithful
to high-frequency rVLM stimulation, and displayed constant
onset latency (Fig. 4).
We examined the activity of elPBN cardiovascular neurons
in response to CSAN stimulation before and after blockade of
glutamate receptors. We found that their activity in response to
repeated epicardial application of BK was unchanged follow-
ing iontophoresis of 0.9% normal saline into the elPBN (n 4;
Fig. 5A). However, the increased discharges induced by epi-
cardial stimulation with BK or electrical CSAN stimulation
were significantly attenuated after iontophoresis of Kyn into
the elPBN (n 6; Fig. 5, B and D). Basal activity of the elPBN
cardiovascular neurons was not altered after administration of
Kyn or 0.9% normal saline (Fig. 5).
Activation of Excitatory elPBN-rVLM Projection During
CSAN Stimulation
rVLM cardiovascular neurons. We identified 25 rVLM
cardiovascular neurons that were responsive to baroreceptor
stimulation (Fig. 6A) and exhibited cardiac rhythmicity with
time and frequency domain analyses (Fig. 6, B and C) in 25
cats. We observed cardiac rhythmicity with a strong correlation
between rVLM activity and BP (coherence 0.85  0.02).
These 25 cells were responsive to both epicardial stimulation
with BK and electrical CSAN stimulation. Their responses to
epicardial stimulation with BK started after	9–14 s and lasted
for 40–100 s. Using spike-triggered averaging and coherence
analyses, we noted a strong relationship between rVLM activ-
ity and RSNA (Fig. 6, D and E) in 18 of the 25 cardiovascular
neurons (coherence 0.70  0.14). These data suggest that the
majority of the cardiovascular cells discharge in synchrony
with the renal sympathetic nerves. They likely function as
presympathetic neurons, as we and others have shown (7, 18,
22, 36). The 25 cardiovascular neurons were examined with the
following protocols.
Protocol 1: rVLM neuronal response to CSAN stimulation
after blockade of glutamate receptors in the elPBN. Both
epicardial stimulation with BK and electrical CSAN stimula-
tion led to consistent increases in the activity of rVLM cardio-
vascular neurons before and after microinjection of aCSF into
the elPBN (n  5; Fig. 7, A and C). In contrast, microinjection
of Kyn into the elPBN significantly attenuated the increased
rVLM activity induced by BK stimulation (n 5; Figs. 7B and
8) and electrical CSAN stimulation (Fig. 7D). Blockade of
regions surrounding the elPBN did not influence rVLM activity
in response to CSAN stimulation in two cells not included
Fig. 4. Antidromic collision of an elPBN cardiovascular neuron. Left to right: time of stimulation of cardiac sympathetic afferent nerves (CSAN; 2),
CSAN-evoked elPBN spike (), time of antidromic stimulation from rostral ventrolateral medulla (rVLM; ), and antidromic-evoked elPBN action potential (Œ).
The neuron had a conduction velocity of 2.0 m/s, an antidromic latency of 4.0 ms, and a refractory period of 1.6 ms. Middle trace displays cancellation of the
antidromic spike by the CSAN-evoked orthodromic spike.
R417INFLUENCE OF elPBN ON rVLM DURING CARDIAC STIMULATION
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00127.2016 • www.ajpregu.org
Downloaded from www.physiology.org/journal/ajpregu by ${individualUser.givenNames} ${individualUser.surname} (128.200.223.175) on July 28, 2018.
Copyright © 2016 American Physiological Society. All rights reserved.
statistical analysis. Thus, 10 of 12 cardiovascular neurons are
presented in protocol 1.
Protocol 2: rVLM neuronal response to elPBN excitation
before and after blockade of rVLM glutamate receptors. Mi-
croinjection of aCSF, the vehicle for DLH, into the elPBN did
not influence rVLM activity in the absence and presence of
electrical CSAN stimulation, as described above (Fig. 7, A and
C). In contrast, in 13 other rVLM cardiovascular neurons
(separate from the 12 cardiovascular neurons tested in protocol
1), repeated microinjections of DLH (2 nmol/50 nl) into the
elPBN consistently increased rVLM activity (Fig. 9). The
DLH-induced increase in basal rVLM activity was not altered
following iontophoresis of 0.9% normal saline into the rVLM
(n  6; Fig. 9B) but was reversed after iontophoresis of Kyn
into the rVLM (n  7, P  0.05; Fig. 9C). Similarly, repeated
microinjections of DLH into the elPBN consistently enhanced
CSAN-evoked rVLM activity with iontophoresis of 0.9% nor-
mal saline into the rVLM (Fig. 9D). However, the enhanced
CSAN-evoked rVLM activity by microinjection of DLH into
the elPBN was significantly reduced after iontophoresis of Kyn
into the rVLM (Fig. 9E). This reduction recovered 50–60 min
later.
Anatomical Location of Recording and Stimulating Sites
Thirty-five sites of recording and microinjection (Fig. 10)
were inside the elPBN, as identified by Berman’s atlas for cats
and consistent with our previous studies (4, 11, 16, 17). All
sites in the elPBN were confined to a region 9.5–11.2 mm
rostral to obex, 4.8–5.4 mm lateral to midline, and 0.7–2.1 mm
from the dorsal surface of the pons, consistent with our previ-
ous study (11, 16). Two microinjections of Kyn were not
located in the elPBN (Fig. 10, B).
All recording sites in the rVLM were confined to an area
2.8–4.2 mm rostral to obex, 2.9–3.7 mm lateral to midline,
and 0.2–1.4 mm from the ventral surface, lateral to the inferior
olive and pyramidal tracts, as well as ventral and medial to the
facial and retrofacial nuclei (Fig. 10). These recording sites
were located within the rVLM, as described by our group and
others (5, 7, 18, 19, 31, 36, 42). Both the right and left sides of
the elPBN and rVLM were used for microinjections and
neuronal recordings in the present study. However, to more
clearly show sites of microinjections and neuronal recordings,
we illustrate all the sites on the left side of composite maps,
since neural structures are identical in both sides of the brain
region.
DISCUSSION
The present study focused on the potential role of elPBN
cardiovascular neurons in regulation of rVLM neuronal activ-
ity through direct glutamatergic elPBN-rVLM pathways during
cardiac sympathetic afferent stimulation. We found that car-
diovascular neurons were present in the elPBN and that their
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activity was increased by activation of cardiac afferents fol-
lowing epicardial application of BK and electrical stimulation
of the inferior cardiac sympathetic nerve. We also observed
that blockade of glutamate receptors in the elPBN reversed the
increased activity of cardiovascular neurons in the elPBN and
rVLM during activation of cardiac sympathetic afferents, sug-
gesting that elPBN cardiovascular neurons process cardiac
sympathetic afferent input through glutamate to stimulate ac-
tivity of rVLM cardiovascular neurons. Furthermore, using a
track-tracing anatomical approach and antidromic stimulation
from the rVLM, we observed that activated elPBN neurons,
including cardiovascular neurons, project directly to the rVLM
following cardiac sympathetic afferent stimulation. We also
found that blockade of glutamate receptors in the rVLM
reversed the impact of activated elPBN neurons on both basal
activity of rVLM cardiovascular neurons and their increased
activity during cardiac sympathetic activation. In addition, we
noted that VGLUT3 was expressed in rVLM-projecting elPBN
neurons activated by cardiac sympathetic afferent stimulation.
These data suggest involvement of glutamate in direct projec-
tions between the elPBN and the rVLM in response to cardiac
sympathetic afferent stimulation. Together, our results indicate
that elPBN cardiovascular neurons, activated by cardiac sym-
pathetic afferent stimulation, facilitate rVLM activity through
direct glutamatergic projections from the elPBN to the rVLM.
Our previous study showed that the elPBN plays an impor-
tant role in regulation of pressor reflexes induced by epicardial
application of BK (11). Other investigators have demonstrated
that the LPBN, including the elPBN, contains heterogeneous
populations of neurons involved in the regulation of respira-
tory, cardiovascular, and gastrointestinal function (13, 23, 29).
Hayward and Felder (23) reported that many neurons in the
LPBN are responsive to peripheral chemoreceptor and barore-
ceptor inputs. They showed that most of the LPBN neurons are
excited following chemoreceptor stimulation and that a major-
ity of LPBN cells are inhibited by activation of baroreceptors
(23). Unfortunately, they did not identify the cardiac rhythmic-
ity of these PBN neurons. We and others have suggested that,
in brain regions, like the rVLM and the NTS, cardiovascular
neurons, by displaying both barosensitivity and cardiac rhyth-
micity, play a crucial role in cardiovascular regulation (1, 3, 18,
22, 36, 42). However, to our knowledge, no study has identi-
fied cardiovascular neurons in the elPBN and examined their
activation by cardiac sympathetic afferent stimulation. In the
present study we identified 12 cardiovascular neurons in the
elPBN that were excited during epicardial stimulation with BK
Fig. 6. Characterization of an rVLM cardiovascular
neuron with sympathetic-related activity. A: intrave-
nous administration of phenylephrine increased
blood pressure (BP) and reduced neuronal activity
(NA). B: pulse-triggered averaging demonstrated a
correlation between BP and NA. C: frequency do-
main analysis showing a significant coherence (0.90
with frequency of 3.45 Hz) between BP and NA. D:
NA and renal sympathetic nerve activity (RSNA).,
Spike of the rVLM neuron. E: NA displayed similar
rhythmicity with RSNA (coherence of 0.60 with
frequency of 3.45 Hz). AS, autospectra.
R419INFLUENCE OF elPBN ON rVLM DURING CARDIAC STIMULATION
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00127.2016 • www.ajpregu.org
Downloaded from www.physiology.org/journal/ajpregu by ${individualUser.givenNames} ${individualUser.surname} (128.200.223.175) on July 28, 2018.
Copyright © 2016 American Physiological Society. All rights reserved.
and electrical cardiac sympathetic afferent stimulation. Fur-
thermore, we observed that the increased activity of these
elPBN neurons is suppressed following blockade of glutamate
receptors in the elPBN. These new findings are congruent with
our previous data on sympathoexcitatory pressor responses
induced by epicardial stimulation with BK (11), indicating that
cardiovascular neurons in the elPBN are excited by glutamate
during cardiac sympathetic afferent activation.
Anatomical and functional evidence has shown connections
between the elPBN and the rVLM in rats and cats (7, 13, 30a,
35, 39). An anterograde autoradiographic study showed con-
nections between the LPBN and the rVLM in rats (39). In cats,
Miura and Takayama (35) reported that microinjection of
glutamate into the LPBN induces a pressor-depressor response
through LPBN-rVLM projections. Although with c-Fos we
previously observed that cardiac sympathetic afferent stimula-
tion activated elPBN neurons in cats (17), it was unclear
whether these activated elPBN neurons project directly to the
rVLM. The present study used a double-labeling approach in
rats to verify direct projections from cardiac sympathetic-
activated elPBN cells to the rVLM. Similarly, antidromic
stimulation of the rVLM activated elPBN cardiovascular neu-
rons in cats. Since numerous studies indicate that the anatom-
ical circuitry in the cardiovascular responses in rats and cats is
virtually identical (6, 7, 21, 25, 42, 49), we believe that the
physiological and anatomical data obtained in the current study
in the two species are mutually supportive.
We observed previously in cats that cardiac sympathetic-
activated elPBN neurons contain VGLUT3 (17). VGLUT3
transports glutamate into neuronal vesicles and, thus, is con-
sidered by many to be a useful marker to identify neurons that
use glutamate as a neurotransmitter (9, 15, 17, 32). The present
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Fig. 7. Influence of blockade of glutamate receptors in the
elPBN on the discharges of rVLM cardiovascular neu-
rons in response to stimulation of cardiac sympathetic
afferent nerves (CSAN). A and B: CSAN stimulation with
application of bradykinin (BK, 2 g). C and D: electrical
CSAN stimulation (E-CSAN). A and C: microinjection of
artificial cerebrospinal fluid (aCSF) into the elPBN. B and
D: microinjection of kynurenic acid (Kyn, 25 mM) into
the elPBN. *P  0.05, after vs. before BK stimulation.
#P 0.05, after vs. before microinjection of Kyn into the
elPBN. E1 and E2 in hatched-bar histograms in D repre-
sent peristimulus histograms of an individual neuron
shown in E1 and E2. Arrows in E1 and E2 indicate
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anatomical data documented VGLUT3 expression in rVLM-
projecting elPBN neurons, suggesting its potential influence.
Furthermore, the present electrophysiological results demon-
strate that blockade of glutamate inotropic receptors in the
rVLM reverses both the enhanced basal and cardiac sympa-
thetic afferent-evoked rVLM discharge induced during excita-
tion of the elPBN with DLH. Together, these results suggest
that elPBN glutamatergic neurons projecting directly to the
rVLM are involved in central neural processing during cardiac
sympathetic nerve stimulation.
In the present studies, using frequency and time domain
analyses, we identified cardiovascular neurons in the elPBN
and rVLM on the basis of their responses to activation/inhibi-
tion of baroreceptors and their relationships to cardiac rhyth-
micity, as documented by our group and others (14, 18, 22, 27,
36, 42, 43). Moreover, sympathetic-related activity is observed
in the majority (72%) of the rVLM cells. As such, rVLM
cardiovascular neurons tested in the present study likely func-
tion as sympathoexcitatory neurons, as we and others have
shown previously (7, 18, 22, 36). However, previous studies
have not examined the influence of elPBN cardiovascular
neurons on the rVLM sympathoexcitatory neuronal activity
during activation of CSAN. The present study demonstrates
that blockade of glutamate receptors in the elPBN attenuates
the increased activity of the rVLM cardiovascular neurons
during CSAN stimulation, while excitation of cell bodies, but
Fig. 8. Activity of an rVLM cardiovascular neuron in
response to epicardial application of bradykinin (BK, 2
g) before (A) and 5 min after (B) unilateral microin-
jection of kynurenic acid (Kyn, 25 mM) into the elPBN
in 1 cat. A and B: an rVLM action potential (top),
neuronal traces displaying rVLM activity (middle), and
original arterial blood pressure (BP) recordings (bot-
tom). Arrows indicate BK application.
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not fibers of passage in the elPBN with DLH (1, 7), increases
the basal and CSAN-evoked activity of the rVLM cardiovas-
cular neurons. These physiological data indicate that elPBN
cardiovascular neurons participate in central regulation of
rVLM neuronal activity through elPBN-rVLM projections dur-
ing cardiac sympathetic afferent stimulation.
There are two potential limitations in the present study. First,
although we were able to record the activity of elPBN neurons
in response to antidromic stimulation in the rVLM, it was not
feasible technically to stimulate and record the same neuron
simultaneously. Thus we were unable to test responsiveness of
both elPBN and rVLM neurons following cardiac sympathetic
afferent stimulation and to examine if blocking elPBN neurons
attenuates increased rVLM activity during cardiac sympathetic
afferent stimulation in a single antidromic experiment. How-
ever, we have shown that inhibition of elPBN neurons (possi-
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bly including rVLM-projecting neurons) attenuate increased
rVLM activity induced by cardiac sympathetic afferent activa-
tion. Thus the present anatomical and physiological findings, in
combination, suggest that elPBN cardiovascular neurons pro-
jecting to the rVLM likely influence rVLM activity during
cardiac sympathetic afferent activation.
Second, in the present immunohistochemical experi-
ments, we employed VGLUT3 as a marker of potential
glutamatergic pathways in the elPBN-rVLM projections
during cardiac sympathetic activation. There is a possibility
that GABAergic and/or cholinergic pathways play a role in
the elPBN-rVLM projection, since previous studies reported
that VGLUT3 also is expressed in GABAergic and cholin-
ergic neurons (9, 15, 17). However, the present electrophys-
iological data show that blockade of glutamate receptors in the
rVLM reverses the impact of activated elPBN neurons on
rVLM activity, supporting the conclusion that glutamatergic
synaptic transmission is required for elPBN-induced stimula-
tion of rVLM neurons. Furthermore, Gritti et al. (15) showed
that the majority (96–100%) of VGLUT3-labeled neurons
stain positively for phosphate-activated glutaminase, an en-
zyme that synthesizes glutamate from glutamine and is en-
riched in glutamatergic neurons. Therefore, it is likely that
during cardiac sympathetic activation glutamate mediates the
action of the elPBN on rVLM neurons.
Perspectives and Significance
In summary, the present study indicates that elPBN cardio-
vascular neurons regulate rVLM activity through excitatory
elPBN-rVLM projections during cardiac sympathetic afferent
stimulation, suggesting that elPBN and elPBN-rVLM neural
pathways are important in regulation of cardiac sympathoex-
citatory reflex responses. These results extend our understand-
ing of the importance of elPBN cardiovascular neurons and
direct glutamatergic elPBN-rVLM neural pathways in central-
processing sympathoexcitatory reflex responses induced by
cardiac sympathetic afferent stimulation.
The elPBN is also connected to several other nuclei, includ-
ing the hypothalamic paraventricular nucleus and the NTS (7,
13). We have demonstrated that these nuclei also are activated
by cardiac sympathetic afferent stimulation (19, 20), implying
that additional pathways may be involved in central regulation
of rVLM activity and in processing of cardiac-cardiovascular
reflex responses. In this regard, projections among the elPBN-
hypothalamic paraventricular nucleus and/or the elPBN-
NTS may participate in the central regulation of rVLM activity
and cardiac sympathoexcitatory reflex responses during acti-
vation of CSAN (7, 13, 39). No other study has examined the
contribution of the above-mentioned pathways in these pro-
cesses during cardiac sympathetic afferent stimulation. Future
investigations are needed to determine the contributions of the
aforementioned pathways in central regulation of rVLM activ-
ity and sympathoexcitatory reflexes in response to activation of
cardiac afferents, in particular during myocardial ischemia.
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